<DOC>
	<DOCNO>NCT01419483</DOCNO>
	<brief_summary>This study investigate use low carbohydrate diet combine chemotherapy radiation therapy safe tolerate patient .</brief_summary>
	<brief_title>Ketogenic Diet With Concurrent Chemoradiation Pancreatic Cancer</brief_title>
	<detailed_description>Standard treatment pancreatic cancer include chemotherapy concurrent radiation therapy ( chemoradiation ) . This study phase I trial determine safety dietary manipulation chemoradiation pancreatic cancer . Specifically , pre-clinical data mouse study indicate ketogenic diet increase tumor cell kill . Participants : - Utilize specialized ketogenic diet design bionutritional service clinical research unit . This diet begin 2 day chemoradiation continue least 5 week chemoradiation . - Have blood draw research purpose weekly determine measurement oxidative stress - Have urine collect sporadically study determine measurement oxidative stress - Keep diary concomitant medication , side effect , blood sugar - Have follow-up monitor outcomes overall survival</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients must cytological histological diagnosis adenocarcinoma arise pancreas . Adenosquamous cancer acceptable . Cancer stag via AJCC IIA , IIB , III ( T3 T4 , N , M0 ) Age ≥ 18 year ECOG performance status 02 ( Karnofsky &gt; 50 % , see Appendix A ) . Hypertensive medication initiate increase optimal blood pressure control accord standard public health guideline prior start ketogenic diet . Patients must normal organ marrow function define : leukocyte ≥ 3,000/mm3 absolute neutrophil count ≥ 1,500/mm3 platelet ≥ 100,000/mm3 total bilirubin &lt; 3.0 mg/dl Hgb A1C &lt; = 8 % AST ( SGOT ) &lt; = 5 X institutional upper limit normal OR stable decrease test value patient undergone placement intrabiliary stent . Both treat radiation oncologist medical oncologist must agree potential subject 's test value acceptable study accrual . creatinine &lt; 1.5 X institutional upper limit normal OR creatinine clearance ≥ 60 mL/min/1.73 m2 patient creatinine level institutional normal . Not pregnant . Women childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry duration study participation . Should woman become pregnant suspect pregnant participating study , inform treat physician immediately . Ability understand willingness sign write informed consent document . Prior abdominal radiotherapy . Prior therapy , intent treat , current diagnosis pancreatic cancer . Known G6PD ( glucose6phosphate dehydrogenase ) deficiency . Patients corticosteroids reason . Living alone time diet initiation . Other investigational agents/therapy intention treat disease study ( observational imaging trial acceptable ) . Uncontrolled diabetes define hemoglobin A1C level &gt; 8 % ( therapeutic action indicate great 8 % ) . Diabetes mellitus exclusionary provide patient maintain either oral medication insulin . Uncontrolled intercurrent illness include , limited ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation , condition would limit compliance study requirement determine study team member . Pregnant lactating woman : The risk radiation chemotherapy fetus well document . Female male patient ethnic group eligible treatment protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pancreatic neoplasm</keyword>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Ketogenic Diet</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>gemcitabine</keyword>
</DOC>